Arie Belldegrun - 14 Sep 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
14 Sep 2022
Net transactions value
+$800,000
Form type
4
Filing time
16 Sep 2022, 15:13:17 UTC
Previous filing
02 Sep 2022
Next filing
24 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $800,000 +160,000 +64% $5.00 408,693 14 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -160,000 -100% $0.000000* 0 14 Sep 2022 Ordinary Shares 160,000 $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.